New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

The Epidemiology of Invasive Group A Streptococcal Infection and Potential Vaccine Implications: United States, 2000-2004

Rosalyn O’Loughlin, A Roberson, Paul R. Cieslak et al. · Clinical Infectious Diseases · 2007 · 506 citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

Shelly McNeil, Scott A. Halperin, Joanne M. Langley et al. · Clinical Infectious Diseases · 2005 · 305 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Clinical and Microbiological Characteristics of Severe<i>Streptococcus pyogenes</i>Disease in Europe

Bogdan Luca-Harari, Jessica Darenberg, Shona Neal et al. · Journal of Clinical Microbiology · 2009 · 295 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Immunogenicity of a 26-Valent Group A Streptococcal Vaccine

Mary C. Hu, Michael A. Walls, Steven D. Stroop et al. · Infection and Immunity · 2002 · 242 citations · Full text

Life Sciences, Immunology, Immunization +16

Safety and Immunogenicity of a Recombinant Multivalent Group A Streptococcal Vaccine in Healthy Adults

Karen L. Kotloff, Mary C. Corretti, Kathleen Palmer et al. · JAMA · 2004 · 173 citations

Veterinary Medicine, Immunology, Infectious Diseases +17